Jefferies Financial Group Inc. Abb Vie Inc. Transaction History

Jefferies Financial Group Inc.

$13.5 Billion
Q3 2024

A detailed history of Jefferies Financial Group Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 303,451 shares of ABBV stock, worth $53.5 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

303,451

Previous 279,721 8.48%

Holding current value

$53.5 Million

Previous $48 Million 24.9%

% of portfolio

0.44%

Previous 0.54%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $3.89 Million - $4.73 Million	23,730 Added 8.48%	303,451 $59.9 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $33.5 Million - $39.1 Million	216,167 Added 340.13%	279,721 $48 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $10.2 Million - $11.6 Million	63,554 New	63,554 $11.6 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $144,010 - $166,712	-1,078 Reduced 5.22%	19,562 $2.92 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $18.1 Million - $22.5 Million	-136,480 Reduced 86.86%	20,640 $2.78 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $8.45 Million - $9.73 Million	58,447 Added 59.23%	157,120 $25 Million
Q4 2022 Sep 21, 2023	BUY	$138.31 - $165.87 $9.64 Million - $11.6 Million	69,679 Added 337.59%	90,319 $14.6 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $13.6 Million - $16.4 Million	98,673 New	98,673 $16 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $1.12 Million - $1.43 Million	-17,028 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $1.83 Million - $2.16 Million	-23,777 Reduced 58.27%	17,028 $1.37 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $56,441 - $69,607	725 Added 1.81%	40,805 $3.76 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $671,359 - $746,340	7,551 Added 23.21%	40,080 $3.79 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $2.92 Million - $3.46 Million	32,529 New	32,529 $3.01 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $470,079 - $629,479	-5,109 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $457,562 - $501,754	5,109	5,109 $494,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Account

Jefferies Financial Group Inc. Abb Vie Inc. Transaction History